Sunesis Pharmaceuticals (NASDAQ:SNSS) Stock Rating Lowered by Zacks Investment Research
Zacks Investment Research lowered shares of Sunesis Pharmaceuticals (NASDAQ:SNSS) from a strong-buy rating to a hold rating in a research ...
Zacks Investment Research lowered shares of Sunesis Pharmaceuticals (NASDAQ:SNSS) from a strong-buy rating to a hold rating in a research ...
Most American adults own life insurance, yet the buying process can be perplexing and pose traps for the unwary — ...
No matter who you ask, everyone agrees that draft preparation is one of the most important parts of a fantasy ...
BidaskClub upgraded shares of Ebix (NASDAQ:EBIX) from a strong sell rating to a sell rating in a report released on ...
“Admitted or not,” wrote the author, psychiatrist James E. Groves, “the fact remains that a few patients kindle aversion, fear, ...
Portland Public Schools is in the early stages of figuring out what a massive construction bond slated for the November ...
Half of adults aged 65 and over who live alone don't have the money to cover their basic needs, according ...
New trivago study of global C-suite and founder sentiment indicates EU firms are growing more competitive in tech and are increasingly ...
Zacks Investment Research cut shares of Santander Consumer USA (NYSE:SC) from a hold rating to a strong sell rating in ...
Since October of last year I have had the opportunity to work with an startup working on automated machine learning ...
© 2025 researchsnappy.com